You are here: Industry Insights > COVID-19

News List

EIB, CEPI Sign Agreement to Accelerate Infectious Disease Vaccination Development americanpharmaceuticalreview
May 04, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) and the European Investment Bank (EIB) signed an advisory agreement to collaborate on the development of innovative financing schemes to support vaccines development across the globe.
SeaStar to Study Selective Cytopheretic Device in COVID-19 Patients with ARDS, Kidney Injury americanpharmaceuticalreview
May 04, 2020
SeaStar Medical has received approval of their Investigational Device Exemption (IDE) supplement from the U.S. Food and Drug Administration (FDA) to initiate a feasibility, compassionate use study.
Fujifilm Diosynth Biotechnologies Teams with COVID-19 Therapeutics Accelerator contractpharma
May 04, 2020
To reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies.
CSIR identifies top 25 drugs/drug candidates for repurposing expresspharma
May 04, 2020
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs.
GBRC signs MoU with Neuberg Supratech for coronavirus vaccine expresspharma
May 04, 2020
Neuberg Supratech will look for immune markers for the COVID-19 positive patients with the use of its in-house high throughput sequencing machines.
Gemini Bio Helps Support COVID-19 Research contractpharma
May 04, 2020
Key products including the Moxi Go are supporting the fight against COVID-19.
ILC Therapeutics Discovers Novel Potential Covid-19 Treatments contractpharma
May 04, 2020
ILC Therapeutics has discovered two separate novel treatments for Covid-19 patients before they are put on ventilators. The UK-based firm is now urgently seeking funding of £4 million to accelerate safety studies and clinical trials.
Moderna signs ten-year vaccine manufacturing deal with Lonza pharmaceutical-technology
May 04, 2020
Moderna has signed a ten-year agreement with Lonza for large-scale manufacture of its vaccine candidate, mRNA-1273, against Covid-19 and other products in the future.
Gilead Granted EUA for Remdesivir in COVID-19 contractpharma
May 04, 2020
Facilitates broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease.
CTI Biopharma Announces Phase 3 Pacritinib for COVID-19 Hospitalized Patients americanpharmaceuticalreview
April 30, 2020
CTI BioPharma announced the initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized patients with severe COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page